Synthetic Derivatives of Ciclopirox are Effective Inhibitors of Cryptococcus neoformans

• Jeffrey Lin,
• Maryam Zangi,
• Tanguturi Venkata Narayana Hajay Kumar,
• Makala Shakar Reddy,
• Lingala Vijaya Raghava Reddy,
• Subir Kumar Sadhukhan,
• Daniel P. Bradley,
• Brenda Moreira-Walsh,
• Tiffany C. Edwards,
• Austin T. O’Dea,
• John E. Tavis,
• Marvin J. Meyers,
• Maureen J. Donlin

Affiliations

Jeffrey Lin

Department of Biology, Saint Louis University, St. Louis, Missouri, United States

Maryam Zangi

Department of Chemistry, Saint Louis University, St. Louis, Missouri, United States

Tanguturi Venkata Narayana Hajay Kumar

Medicinal Chemistry Division, Albany Molecular Research Inc., Hyderabad, India

Makala Shakar Reddy

Medicinal Chemistry Division, Albany Molecular Research Inc., Hyderabad, India

Lingala Vijaya Raghava Reddy

Medicinal Chemistry Division, Albany Molecular Research Inc., Hyderabad, India

Subir Kumar Sadhukhan

Medicinal Chemistry Division, Albany Molecular Research Inc., Hyderabad, India

Daniel P. Bradley

Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, Missouri, United States

Brenda Moreira-Walsh

Edward A. Doisy Department of Biochemistry, Saint Louis University School of Medicine, St. Louis, Missouri, United States

Tiffany C. Edwards

Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, Missouri, United States

Austin T. O’Dea

Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, Missouri, United States

John E. Tavis

Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, St. Louis, Missouri, United States

Marvin J. Meyers

Department of Chemistry, Saint Louis University, St. Louis, Missouri, United States

Maureen J. Donlin

Edward A. Doisy Department of Biochemistry, Saint Louis University School of Medicine, St. Louis, Missouri, United States